From the Journals

Heavy drinking in your 20s has lasting impact on cancer risk


 

FROM THE INTERNATIONAL JOURNAL OF CANCER

‘Striking’ findings

Reached for comment, Timothy Brennan, MD, MPH, chief of clinical services at the Addiction Institute of Mount Sinai in New York, said it is “striking” that heavy drinking in early adulthood led to an increased risk for alcohol-related cancers, even among people who drank much less in middle age.

“We’ve known for decades that alcohol is not harmless, but this data adds to the growing body of literature regarding the significant dangers of heavy drinking during early adulthood,” said Dr. Brennan, who wasn’t involved in the study.

Dr. Brennan cautioned, however, that the authors studied alcohol-related cancers, and “there are likely many other [cancer] risk factors that were not analyzed in this dataset.”

Nevertheless, this evidence helps counter the “troubling narrative” that “it is somehow normal and safe to drink excessively in young adulthood.”

“It is most certainly not safe,” Dr. Brennan told this news organization . “We see in this study that drinking excessively in young adulthood can raise the risk of cancer much later in life.”

The study had no commercial funding. Dr. Bassett, Dr. Jayasekara, and Dr. Brennan have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Lung cancer now a growing public health threat
MDedge Internal Medicine
Complex link between gut microbiome and immunotherapy response in advanced melanoma
MDedge Internal Medicine
Sotorasib demonstrates clinically meaningful difference in pancreatic cancer
MDedge Internal Medicine
Chemotherapy and radiation before surgery boosts pancreatic cancer survival
MDedge Internal Medicine
Testicular cancer mortality rates dip for Hispanic men
MDedge Internal Medicine
MRI with mammogram reduces breast cancer mortality by more than 50% in high-risk women
MDedge Internal Medicine
Filling opioid prescriptions akin to a Sisyphean task
MDedge Internal Medicine
Height an ‘overlooked risk factor’ for colorectal cancer?
MDedge Internal Medicine
No new safety signals reported for pembrolizumab as kidney cancer treatment
MDedge Internal Medicine
Why is there an increased risk of cancer in depressed patients?
MDedge Internal Medicine